Tolvaptan
- 1 trial, none about aging
Latest
3 in 12 monthsScience Progress
Association of semaglutide use with kidney outcomes in adults with ADPKD: A propensity score-matched real-world study
Cohort study of 45,613 peopleSemaglutide
Clinical Journal of the American Society of Nephrology
The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient Care
ReviewKidney
Current Opinion in Nephrology and Hypertension
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan
ReviewKidney
bioRxiv
Discovery and Repurposing of Multi-Target Senolytics through Structure-Based Virtual Screening
Preprint: experiments in cellsInterventions